Literature DB >> 21427079

Maximal glomerular diameter as a 10-year prognostic indicator for IgA nephropathy.

Hiroshi Kataoka1, Mamiko Ohara, Kazuho Honda, Takahiro Mochizuki, Kosaku Nitta.   

Abstract

BACKGROUND: Although there have been many reports on clinicopathological studies of immunoglobulin A nephropathy (IgAN), reliable outcome predictors are still lacking. We therefore assessed maximal glomerular diameter (Max GD), an indicator of glomerular size, as a predictor of the long-term evolution of renal histopathology.
METHODS: Forty-three adult patients, diagnosed with IgAN, who had estimated glomerular filtration rate (eGFR) ≥50 mL/min/1.73 m(2), were enrolled in this study. Prognostic variables for renal survival were examined by using the multivariate Cox proportional hazards method. The optimal cut-off value of Max GD was 242.3 μm (AUC = 0.78, sensitivity = 62.5%, specificity = 81.5%) by using receiver operating characteristics analysis. In order to assess the characteristics of glomerular hypertrophy, we divided the cases into two groups according to the Max GD value (Group A, ≥242 μm; Group B, <242 μm). Renal survival was also assessed by Kaplan-Meier curves with the log-rank test.
RESULTS: The Max GD was significantly correlated with age, body mass index and serum triglyceride levels at the time of renal biopsy. During the 10-year follow-up period, the Max GD was significantly correlated with eGFR decline per year, and proteinuria, but not with hematuria. A multiple regression analysis by the Cox method adjusted for age, sex and eGFR showed that the Max GD values were significantly associated with a 1.5-fold increase in serum creatinine (Cr) values (hazard ratio = 1.04, P = 0.03). Renal function in 66.7% of the patients whose Max GD was ≥242 μm had at least a 1.5-fold increase in their serum Cr value at the 10-year follow-up examination (log-rank, P = 0.003).
CONCLUSIONS: The results of this study suggest that Max GD is a simple quantitative prognostic indicator of the disease progression in IgAN patients.

Entities:  

Mesh:

Year:  2011        PMID: 21427079     DOI: 10.1093/ndt/gfr139

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  16 in total

1.  Relationship between dietary protein intake and the changes in creatinine clearance and glomerular cross-sectional area in patients with IgA nephropathy.

Authors:  Toshikazu Wada; Toshiyuki Nakao; Hiroshi Matsumoto; Tomonari Okada; Yume Nagaoka; Hideaki Iwasawa; Asako Gondo; Ami Niwata; Yoshihiko Kanno
Journal:  Clin Exp Nephrol       Date:  2014-11-16       Impact factor: 2.801

Review 2.  IgA Nephropathy.

Authors:  Jennifer C Rodrigues; Mark Haas; Heather N Reich
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-03       Impact factor: 8.237

3.  Impact of visceral fat area in patients with chronic kidney disease.

Authors:  Shun Manabe; Hiroshi Kataoka; Toshio Mochizuki; Kazuhiro Iwadoh; Yusuke Ushio; Keiko Kawachi; Kentaro Watanabe; Saki Watanabe; Taro Akihisa; Shiho Makabe; Masayo Sato; Naomi Iwasa; Rie Yoshida; Yukako Sawara; Norio Hanafusa; Ken Tsuchiya; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2021-02-17       Impact factor: 2.801

Review 4.  [Pathophysiology and treatment of IgA nephropathy].

Authors:  R Bollin; H Haller
Journal:  Internist (Berl)       Date:  2018-07       Impact factor: 0.743

Review 5.  Treatment of IgA nephropathy and Henoch-Schönlein nephritis.

Authors:  Jürgen Floege; John Feehally
Journal:  Nat Rev Nephrol       Date:  2013-04-02       Impact factor: 28.314

6.  Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters.

Authors:  Hiroshi Kataoka; Mamiko Ohara; Kaori Shibui; Masayo Sato; Tomo Suzuki; Nobuyuki Amemiya; Yoshihiko Watanabe; Kazuho Honda; Takahiro Mochizuki; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-02-17       Impact factor: 2.801

7.  Clinical, Pathological, and Genetic Characteristics in Patients with Focal Segmental Glomerulosclerosis.

Authors:  China Nagano; Shigeo Hara; Norishige Yoshikawa; Asami Takeda; Yoshimitsu Gotoh; Riku Hamada; Kentaro Matsuoka; Masaki Yamamoto; Shuichiro Fujinaga; Koji Sakuraya; Koichi Kamei; Yuko Hamasaki; Hideyo Oguchi; Yoshinori Araki; Yayoi Ogawa; Takayuki Okamoto; Shuichi Ito; Seiji Tanaka; Hiroshi Kaito; Yuya Aoto; Shinya Ishiko; Rini Rossanti; Nana Sakakibara; Tomoko Horinouchi; Tomohiko Yamamura; Hiroaki Nagase; Kazumoto Iijima; Kandai Nozu
Journal:  Kidney360       Date:  2022-05-24

8.  Clinicopathological assessment of the nephron number.

Authors:  Nobuo Tsuboi; Go Kanzaki; Kentaro Koike; Tetsuya Kawamura; Makoto Ogura; Takashi Yokoo
Journal:  Clin Kidney J       Date:  2014-03-11

9.  Pathological similarities between low birth weight-related nephropathy and nephropathy associated with mitochondrial cytopathy.

Authors:  Toshiyuki Imasawa; Masashi Tanaka; Naoki Maruyama; Takehiko Kawaguchi; Yutaka Yamaguchi; Rodrigue Rossignol; Hiroshi Kitamura; Motonobu Nishimura
Journal:  Diagn Pathol       Date:  2014-09-30       Impact factor: 2.644

10.  Aspartic acid supplementation ameliorates symptoms of diabetic kidney disease in mice.

Authors:  Saki Ichikawa; Tomohito Gohda; Maki Murakoshi; Zi Li; Eri Adachi; Takeo Koshida; Yusuke Suzuki
Journal:  FEBS Open Bio       Date:  2020-05-18       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.